Ann: Phase III prophylaxis trial for CS-8958 , page-34

Cgt

Exactly

This news is of interest but not a price sensitive announcement for BTA. One trial of so many. So much we don't know yet they announce this as price sensitive. Lani or relenza prophalyxis revenue isn't built into the bta share price 1 cent.

This is just crazy stuff and what concerns me most of all is that someone smart is going to notice this and make a low ball offer for BTA. East hills etc and break BTAs components up and relist on the NASDAQ etc and make a killing.

You know what. I'm over these guys. They have had enough chances and this insane announcement badly written, on a down day is just the final straw.

If we get a stupid offer from a predator for 1.20 which by the time it happens will be a 50% premium. I am out of here.

They are doing nothing to help the share price as their attitude is it will take care of itself. PC doesn't even agree his number one priority is to increae shareholders wealth. He thinks it's about making sucessfull drugs etc and being conservative and focusing on the science.

He's got it back to front. That is our problem here. PC.